News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
EMANUELE ROBERT MARTIN
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/08/2023 |
4
| EMANUELE ROBERT MARTIN (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns:
| Granted 1,083 options to buy
@ $2.01, valued at
$2.2k
|
|
07/03/2023 |
4
| EMANUELE ROBERT MARTIN (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns:
| Granted 667 options to buy
@ $2.01, valued at
$1.3k
|
|
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/30/2019 |
4
| EMANUELE ROBERT MARTIN (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns:
| Granted 17,500 options to buy
@ $1.99, valued at
$34.8k
|
|
01/06/2016 |
4
| EMANUELE ROBERT MARTIN (Senior VP, Development) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 572,700 options to buy
@ $0.42, valued at
$240.5k
|
|
06/12/2015 |
4
| EMANUELE ROBERT MARTIN (Senior VP, Development) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 291,500 options to buy
@ $0.5, valued at
$145.8k
|
|
01/02/2015 |
4
| EMANUELE ROBERT MARTIN (Senior VP, Development) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 500,250 options to buy
@ $0.58, valued at
$290.1k
|
|
06/20/2014 |
4
| EMANUELE ROBERT MARTIN (Senior VP, Development) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 285,400 options to buy
@ $0.65, valued at
$185.5k
|
|
01/03/2014 |
4
| EMANUELE ROBERT MARTIN (Senior VP, Development) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 115,900 options to buy
@ $0.47, valued at
$54.5k
|
|
05/31/2013 |
4
| EMANUELE ROBERT MARTIN (Senior VP, Development) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 52,543 shares
@ $0 |
|
01/18/2013 |
4
| EMANUELE ROBERT MARTIN (Senior VP, Development) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC
Txns:
| Disposed of 305,608 shares
@ $0.001, valued at
$305.6 |
|
12/19/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|